Affecting 1 in 3000 individuals worldwide, approximately 50% of NF1 patients develop plexiform neurofibromas (PNs), a histologically benign heterogeneous nervous sheath tumor arising from Schwann cells that display harbor a biallelic NF1 inactivation. The gene discussed is NF1; the disease is paraneoplastic neurologic syndrome.